StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.06−2.59 (-2.92%)

Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –

Solventum revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Solventum's revenue for the twelve months ending Sep 30, 2026 was $8.16B, down 2.8% year over year. For fiscal 2025 it was $8.33B, up 0.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.33B+0.9%
FY2024Dec 31, 2024$8.25B+0.7%
FY2023Dec 31, 2023$8.20B+0.8%
FY2022Dec 31, 2022$8.13B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.95B-7.0%
Q2 FY2026Jun 30, 2026$2.21B+2.2%
Q1 FY2026Mar 31, 2026$2.01B-3.0%
Q4 FY2025Dec 31, 2025$2.00B-3.7%
Q3 FY2025Sep 30, 2025$2.10B+0.7%
Q2 FY2025Jun 30, 2025$2.16B+3.8%
Q1 FY2025Mar 31, 2025$2.07B+2.7%
Q4 FY2024Dec 31, 2024$2.08B+1.9%
Q3 FY2024Sep 30, 2024$2.08B+0.4%
Q2 FY2024Jun 30, 2024$2.08B+0.2%
Q1 FY2024Mar 31, 2024$2.02B+0.2%
Q4 FY2023Dec 31, 2023$2.04B–
Q3 FY2023Sep 30, 2023$2.07B–
Q2 FY2023Jun 30, 2023$2.08B–
Q1 FY2023Mar 31, 2023$2.01B–

More Solventum figures

See a number that looks wrong?